AdvanSix (NYSE:ASIX - Get Free Report) SVP Achilles B. Kintiroglou sold 571 shares of AdvanSix stock in a transaction dated Wednesday, July 2nd. The stock was sold at an average price of $24.85, for a total value of $14,189.35. Following the completion of the sale, the senior vice president directly owned 31,984 shares of the company's stock, valued at approximately $794,802.40. This trade represents a 1.75% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
AdvanSix Stock Performance
ASIX stock traded up $0.19 during trading on Friday, reaching $25.29. The company had a trading volume of 90,943 shares, compared to its average volume of 153,571. The firm has a 50-day simple moving average of $23.63 and a 200-day simple moving average of $25.37. The company has a market cap of $678.02 million, a price-to-earnings ratio of 8.11 and a beta of 1.60. AdvanSix has a twelve month low of $18.44 and a twelve month high of $33.00. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.56 and a current ratio of 1.19.
AdvanSix Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th were issued a dividend of $0.16 per share. The ex-dividend date was Tuesday, May 13th. This represents a $0.64 annualized dividend and a yield of 2.53%. AdvanSix's dividend payout ratio is currently 20.51%.
Analyst Upgrades and Downgrades
Several equities analysts have commented on the company. Wall Street Zen raised AdvanSix from a "buy" rating to a "strong-buy" rating in a research report on Saturday, May 31st. Piper Sandler set a $32.00 price target on AdvanSix in a report on Monday, May 19th. Finally, UBS Group set a $35.00 price objective on shares of AdvanSix in a research report on Tuesday, March 18th.
Read Our Latest Stock Report on AdvanSix
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in ASIX. Ameriprise Financial Inc. grew its holdings in shares of AdvanSix by 0.3% during the 4th quarter. Ameriprise Financial Inc. now owns 135,127 shares of the company's stock worth $3,850,000 after purchasing an additional 450 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in AdvanSix by 3.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,543 shares of the company's stock worth $414,000 after purchasing an additional 508 shares during the last quarter. Oliver Luxxe Assets LLC raised its stake in AdvanSix by 1.1% during the 1st quarter. Oliver Luxxe Assets LLC now owns 49,805 shares of the company's stock valued at $1,128,000 after acquiring an additional 543 shares in the last quarter. Nilsine Partners LLC grew its position in AdvanSix by 2.8% in the 1st quarter. Nilsine Partners LLC now owns 21,891 shares of the company's stock valued at $496,000 after buying an additional 603 shares in the last quarter. Finally, AlphaQuest LLC raised its holdings in AdvanSix by 22.3% during the first quarter. AlphaQuest LLC now owns 4,014 shares of the company's stock worth $91,000 after purchasing an additional 731 shares in the last quarter. Hedge funds and other institutional investors own 86.39% of the company's stock.
AdvanSix Company Profile
(
Get Free Report)
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Featured Stories
Before you consider AdvanSix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.
While AdvanSix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
